Workflow
科思转债
icon
Search documents
19日投资提示:九强生物股东拟合计减持不超4.8%股份
集思录· 2025-05-18 13:35
Group 1 - The core viewpoint of the article is that shareholders of Jiukang Bio plan to reduce their holdings by no more than 4.8% of the company's shares [1] - The article mentions that the Hui Lian convertible bond will undergo a downward adjustment [1] - The board of directors of Puli will propose a downward adjustment for its bonds [1] Group 2 - The article states that Yong 22 convertible bond, Kesi convertible bond, and Jingke convertible bond will not undergo downward adjustments [1] - The article encourages readers to follow the WeChat account of Jisilu for more information [2]
科思股份: 关于不向下修正科思转债转股价格的公告
Zheng Quan Zhi Xing· 2025-05-16 10:37
Core Viewpoint - The company has decided not to adjust the conversion price of its convertible bonds despite triggering the downward adjustment clause due to stock prices falling below 85% of the current conversion price [1][6]. Group 1: Convertible Bond Basic Information - The company issued 7,249,178 convertible bonds at a face value of RMB 100 each, totaling approximately RMB 716.33 million [2]. - The convertible bonds were listed on the Shenzhen Stock Exchange on May 11, 2023, under the name "Kesi Convertible Bonds" with the code "123192" [2]. - The conversion period for the bonds runs from the end of the issuance on April 12, 2023, until the maturity date on April 12, 2029 [2]. Group 2: Conversion Price Adjustment Terms - The initial conversion price was set at RMB 53.03 per share, which was later adjusted to RMB 52.03 per share effective from June 2, 2023 [2]. - The conversion price can be adjusted downward if the company's stock price falls below 85% of the current conversion price for at least 15 trading days within a 30-day period [4][5]. - If the downward adjustment is approved by the shareholders, the new conversion price must not be lower than the higher of the average stock price over the previous 20 trading days or the last trading day before the meeting [4]. Group 3: Recent Board Decision - On May 16, 2025, the board of directors decided not to adjust the conversion price of the "Kesi Convertible Bonds" despite the stock price falling below the threshold [1][6]. - The board will not propose any downward adjustment for the next six months, and if the adjustment clause is triggered again, a new meeting will be convened to decide on the matter [1][6].